US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Purdue Pharma L.P.

Track this case

Case overview

Case Number:

7:19-bk-23649

Court:

New York Southern

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

  1. January 27, 2025

    Purdue Nears Ch. 11 Deal, Yellow Corp. Fends Off WARN Suit

    From a looming settlement in the Purdue bankruptcy to a pair of retailers overcoming objections to their Chapter 11 plans, here are some of the biggest bankruptcy news from the past week.

  2. January 24, 2025

    Sackler Injunction Extended Ahead Of New Purdue Ch. 11 Plan

    A New York bankruptcy judge agreed Friday to extend an injunction blocking litigation against the former owners of Purdue Pharma for another month after being told a deal on a new Chapter 11 plan for the OxyContin maker is imminent.

  3. January 23, 2025

    15 States Reach $7.4B Settlement With Sackler Family

    A bipartisan coalition of states on Thursday announced a $7.4 billion settlement in principle with the Sackler family and their company Purdue Pharma Inc., representing the largest settlement to date with the family accused of contributing significantly to the opioid epidemic.

  4. January 21, 2025

    Last Sackler Family Members Join Purdue Draft Deal

    The final holdouts among two branches of Sackler family members are ready to join a settlement in the bankruptcy of OxyContin maker Purdue Pharma LP, a business owned by the family, according to a report from the co-mediators handling negotiations.

  5. January 13, 2025

    Purdue Pharma Inks Draft Deal, Seeks Mediation Extension

    OxyContin maker Purdue Pharma LP has inked a 50-page term sheet and 75-page draft master settlement agreement that could resolve its more than 5-year-old bankruptcy case after its last plan was tossed out, it said in a New York court filing.

  6. January 02, 2025

    Bankruptcy News You May Have Missed Over The Holiday

    The Fifth Circuit sided with a group of lenders left out of a so-called uptier refinancing deal with mattress seller Serta Simmons, reversing a bankruptcy court's ruling in a closely watched case on liability management transactions; Purdue Pharma secured a one-month extension as its creditors and members of the Sackler family try to reach a settlement in mediation; and retail chain Big Lots reached an eleventh-hour deal to sell some of its stores and thwart a total liquidation.

  7. December 17, 2024

    Purdue, FTX Top Biggest Bankruptcy Cases, Trends Of 2024

    The U.S. Supreme Court's decision to throw out nonconsensual third-party releases in opioid maker Purdue Pharma's Chapter 11 reverberated through the bankruptcy domain in unexpected ways this year, but it was just one among many major events to shape bankruptcy in 2024.

  8. November 26, 2024

    Purdue Wins Shortened Extension Of Ch. 11 Deal Talks

    A New York bankruptcy judge on Tuesday granted Purdue Pharma LP more time to negotiate a new settlement with certain members of the Sackler family who own the bankrupt OxyContin maker, as mediators say they have ironed out a term sheet and are getting ever closer to finalizing a deal.

  9. November 25, 2024

    Alex Jones Blasts Onion Bid, FTX Tech Deputy Avoids Prison

    Alex Jones and a backup bidder linked to his Chapter 7 are challenging the sale of his Infowars website to The Onion, alleging flaws in the auction process. A former FTX's tech deputy can avoid prison time for assisting the FTX fraud case by exposing programming flaws; attorneys who have represented Purdue Pharma can receive $21.2 million in fees for its work during summer. This is the week in bankruptcy.

  10. November 20, 2024

    Lawyers In Purdue Bankruptcy Get OK For Millions In Fees

    More than 150 lawyers, investment bankers and financial advisers representing the creditors committee of bankrupt OxyContin maker Purdue Pharma LP billed $21.2 million as the high-stakes case reignited this summer, according to a Law360 tally of interim fee applications.